CATEGORIES

News and Views

LATEST

TRENDING

EDITORS CHOICE

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

Is the New York Times a Shill for Promoters of Psychedelics?

Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

The Cohen Clinic Expands Mental Health Treatments for Active Duty Service Members

The Cohen Clinic at Metrocare in Addison, Texas now offering individual mental health therapy for active duty service members.

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars raised by venture capitalists.